Clinical Trial Update: Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study [EARLY_Phase 1]

View source ↗

Summary

Early-phase pilot study evaluating safety and preliminary efficacy of the JAK inhibitor tofacitinib in patients with refractory generalized myasthenia gravis. R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Huashan Hospital | Conditions: Myasthenia Gravis, Generalized | EARLY_Phase 1 | Status: COMPLETED